Healthcare / Medical Care FacilitiesHKSE
$0.59
+0.03 (+5.36%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $51000.00 · quality 47.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
37/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$354M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-13.6%
↓Gross Margin
39.1%
↓Debt/Equity
0.13
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-7.2%
FCF CAGR
-36.9%
FCF margin
6.0%
FCF / Net income
-0.42x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $101.7M · net income $-14.3M · FCF $6.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $101.7M | $101.7M | $74.7M | $73.5M | $127.4M |
| Net Income | $-14.3M | $-14.3M | $-32.4M | $-13.6M | $28.5M |
| EBITDA | $-799000.00 | $-799000.00 | $-14.4M | $8.7M | $55.4M |
| EPS | — | — | -0.06 | -0.02 | 0.06 |
| Gross Margin | 39.1% | 39.1% | 36.1% | 44.4% | 61.4% |
| Operating Margin | -20.1% | -20.1% | -43.7% | -14.8% | 32.4% |
| Net Margin | -14.1% | -14.1% | -43.4% | -18.5% | 22.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.13 | 0.13 | 0.28 | 0.20 | 0.21 |
| Current Ratio | 2.15 | 2.15 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $6.1M | $6.1M | $-20.0M | $51000.00 | $24.1M |
| Returns | |||||
| ROE | -13.6% | -13.6% | -27.2% | -8.2% | 16.0% |
| Valuation | |||||
| P/E | — | — | — | — | 9.32 |
| EV/EBITDA | — | — | — | 24.02 | 3.83 |
| P/B | 3.35 | 3.35 | 1.76 | 1.58 | 1.50 |
| Growth & Yield | |||||
| Revenue Growth | 36.2% | 36.2% | 1.6% | -42.3% | — |
| EPS Growth | — | — | -145.4% | -136.5% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+90.3%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.06 → n/d
Residual
+90.3%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.